SRTA
NASDAQStrata Critical Medical Inc.
Price$5.88-0.04 (-0.76%)
01:30 PM07:45 PM
News · 26 weeks39-80%
2025-12-142026-06-07
Mix2590d
- Insider9(36%)
- SEC Filings5(20%)
- Other5(20%)
- Analyst2(8%)
- Earnings2(8%)
- M&A2(8%)
Latest news
25 items- SECStrata Critical Medical Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Strata Critical Medical, Inc. (0001779128) (Filer)
- PRStrata Acquires Louisville Perfusion ServicesNEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (NASDAQ:SRTA, "Strata" or the "Company")), today announced that it has completed the acquisition of Louisville Perfusion Services, Inc. ("LPS"), a regional provider of perfusion and blood management services to cardiac surgery programs in Kentucky. "The acquisition of Louisville Perfusion Services fits perfectly with our existing customer base in Kentucky and Ohio, giving us a new strategic stronghold in the Midwest and Southern United States," said Lou Verdetto, CEO of Strata's Clinical Division. "More than just unlocking the ability to win new perfusion contracts in the region, LPS also expands the national footpr
- INSIDERChief Accounting Officer Cohen Amir sold $299,435 worth of shares (50,875 units at $5.89) as part of a pre-agreed trading plan, decreasing direct ownership by 25% to 151,263 units (SEC Form 4)4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
- INSIDERChief Accounting Officer Cohen Amir sold $82,832 worth of shares (14,306 units at $5.79) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 202,138 units (SEC Form 4)4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
- NEWSAIAI Holdings Corporation Announces Appointment of Board of DirectorsDirectors bring a strong combination of technology, healthcare, national security, leadership experience, and financial and capital markets backgroundsAIAI Expected to Begin Trading on May 14, 2026 DALLAS, TX / ACCESS Newswire / May 12, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai2" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI to enhance portfolio performance, today announced the appointment of the Company's Board of Directors.John P. Rochon leads the 10-person Board as Chairman. Todd A. Furniss, President and CEO of AIAI Holdings Corporation, serves on the Board alongside a distinguished group of leaders in private equity, healthcare, da
- INSIDERSEC Form 4 filed by Large owner Krstic Velibor4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
- PRStrata Critical Medical Announces Expiration of WarrantsNEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (NASDAQ:SRTA, "Strata" or the "Company")), announced that its warrants, both the Public Warrants (NASDAQ:SRTAW) and the Private Placement Warrants, expired in accordance with their original terms at 5:00 p.m. Eastern Time today May 7, 2026. About Strata Critical Medical, Inc. Strata is a time-critical logistics and medical services provider to the U.S. healthcare industry. We operate one of the nation's largest air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated "one call" solution for donor organ recovery. Strata's core services include
- SECSEC Form 25-NSE filed by Strata Critical Medical Inc.25-NSE - Strata Critical Medical, Inc. (0001779128) (Subject)
- SECSEC Form 10-Q filed by Strata Critical Medical Inc.10-Q - Strata Critical Medical, Inc. (0001779128) (Filer)
- SECStrata Critical Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Strata Critical Medical, Inc. (0001779128) (Filer)
- PRStrata Critical Medical Announces First Quarter 2026 ResultsRevenue increased 87.4% year-over-year to $67.4 million in Q1 2026Logistics revenue and gross profit grew 32.4% and 29.9% year-over-year, respectively, in Q1 2026, which represents Strata's organic growthClinical revenue and gross profit sequential growth of 12.7% and 29.2%, respectively in Q1 2026 versus Q4 2025 Q1 2026 net income from continuing operations of $2.4 millionAdjusted EBITDA(1) of $6.4 million in Q1 2026Completed bolt-on acquisition of Ohio Valley Perfusion AssociatesReiterating full year 2026 guidance NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (NASDAQ:SRTA, ", Strata", or the ", Company", )), today announced financial results for the first quar
- PRStrata Acquires Ohio Valley Perfusion AssociatesNEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (NASDAQ:SRTA, ", Strata", or the ", Company", )), today announced that it has completed the acquisition of Ohio Valley Perfusion Associates ("OVPA"), a regional provider of perfusion services to cardiac surgery programs in Ohio and Pennsylvania. "Expanding our presence in Eastern Ohio and Western Pennsylvania is an important step in strengthening Strata's regional clinical platform," said Louis Verdetto, CEO of Strata's Clinical Services Division. "These programs align well with our existing operations and allow us to further leverage our team of highly trained perfusionists to support cardiac surgery programs whil
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Strata Critical Medical Inc.SCHEDULE 13G/A - Strata Critical Medical, Inc. (0001779128) (Subject)
- INSIDERCEO, Logistics Wunsch Scott M was granted 57,172 shares and covered exercise/tax liability with 13,922 shares, increasing direct ownership by 7% to 631,124 units (SEC Form 4) to satisfy withholding obligation4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
- INSIDERChief Accounting Officer Cohen Amir was granted 83,505 shares and covered exercise/tax liability with 40,960 shares, increasing direct ownership by 24% to 216,444 units (SEC Form 4) (for tax liability)4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
- INSIDERCo-CEO and General Counsel Tomkiel Melissa M. was granted 630,264 shares and covered exercise/tax liability with 321,750 shares, increasing direct ownership by 19% to 1,922,504 units (SEC Form 4) to satisfy withholding tax4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
- INSIDERCo-CEO and CFO Heyburn William A. was granted 545,625 shares and covered exercise/tax liability with 301,731 shares, increasing direct ownership by 18% to 1,580,668 units (SEC Form 4) (withholding tax)4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
- PRStrata Critical Medical Schedules First Quarter 2026 Earnings Conference CallNEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical. (NASDAQ:SRTA, "Strata" or the "Company")), will release financial results for the first quarter ended March 31, 2026 on Wednesday May 6, 2026 before the market opens. The company will hold a conference call on the same day at 8:00 am Eastern Time to discuss the results. The call will be hosted by Melissa Tomkiel, Strata's Co-Chief Executive Officer and General Counsel, and Will Heyburn, Strata's Co-Chief Executive Officer and Chief Financial Officer, and will include a question-and-answer session for call participants. To join the live call, please register here. Upon registration, a dial-in and unique PIN will be provi
- SECSEC Form DEFA14A filed by Strata Critical Medical Inc.DEFA14A - Strata Critical Medical, Inc. (0001779128) (Filer)
- SECSEC Form DEF 14A filed by Strata Critical Medical Inc.DEF 14A - Strata Critical Medical, Inc. (0001779128) (Filer)
- PRStrata Critical Medical to Present at the 25th Annual Needham Virtual Healthcare ConferenceNEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (NASDAQ:SRTA, "Strata" or the "Company")), today announced that management will present at the 25th Annual Needham Virtual Healthcare Conference on Wednesday, April 15, 2026, at 1:30 pm ET. A webcast of the event will be available at the link here. A replay will be available shortly after the conclusion of the presentation on the investor relations section of the Company's website at https://ir.stratacritical.com/. About Strata Critical Medical Strata Critical Medical provides time-critical logistics solutions and specialized medical services to healthcare providers across the United States, strategically expandi
- ANALYSTCraig Hallum initiated coverage on Strata Critical Medical with a new price targetCraig Hallum initiated coverage of Strata Critical Medical with a rating of Buy and set a new price target of $8.00
- ANALYSTB. Riley Securities initiated coverage on Strata Critical Medical with a new price targetB. Riley Securities initiated coverage of Strata Critical Medical with a rating of Buy and set a new price target of $8.00
- INSIDERAmendment: SEC Form 4 filed by Cohen Amir4/A - Strata Critical Medical, Inc. (0001779128) (Issuer)
- INSIDERSEC Form 4 filed by Wunsch Scott M4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
SRTA FAQ
6 questionsWhere does SRTA stock trade?
Strata Critical Medical Inc. (SRTA) is listed on NASDAQ.What sector and industry is SRTA in?
Strata Critical Medical Inc. operates in the Consumer Discretionary sector, Transportation Services industry.When did Strata Critical Medical Inc. go public?
Strata Critical Medical Inc. (SRTA) completed its IPO in 2019.What are analysts saying about SRTA?
Strata Critical Medical Inc. has had 3 recent analyst actions on file. The most recent action was from Craig Hallum: Buy with a $800.00 price target on 2026-03-25. Recent price targets cluster around $800.00.What companies are similar to SRTA?
Notable peers in the same industry include BKNG (Booking Holdings Inc.), EXPE (Expedia Group Inc.), XPO (XPO Inc.), GATX (GATX Corporation), GXO (GXO Logistics Inc.). Compare SRTA side-by-side with any of them on Quantisnow.How can I track SRTA on Quantisnow?
Quantisnow aggregates Strata Critical Medical Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SRTA to receive live email and push alerts on every new disclosure.